Team

 

SV Life Sciences has a team of 34 professionals, of which 27 are deal professionals focusing on our portfolio; identifying investment opportunities, structuring and executing transactions, actively working with portfolio companies on development and growth initiatives and achieving investment realizations. The remaining seven team members are finance professionals who provide essential support to the deal teams and our investors. A key strength of the SV Life Sciences team is the breadth of hands-on operational experience in venture capital investment as well as within the Life Sciences industry across operational, scientific and clinical experience.  

 

 

Managing Partners

Kate Bingham
Kate Bingham
Biotechnology

Operating Partner

Hamish Cameron
Hamish Cameron
Biotechnology

Venture Partners

Houman Ashrafian
Houman Ashrafian
Therapeutics
Graham Boulnois
Graham Boulnois
Biotechnology
Michael Carter
Michael Carter
Biotechnology

Finance Team

Nick Coleman
Nick Coleman

Dementia Discovery Fund

Further information is available at www.theDDFund.com

Laurence Barker
Laurence Barker
Biotechnology
Tetsu Maruyama
Tetsu Maruyama
Biotechnology
Carol Routledge
Carol Routledge
Biotechnology


⇧ Back to top